|
市場調査レポート
商品コード
1629625
鎌状赤血球貧血の検査・スクリーニング市場：検査方法別、年齢層別、セクター別、地域別Sickle Cell Anemia Testing and Screening Market, By Testing Method (Hemoglobin Electrophoresis, High-Performance Liquid Chromatography, Point-of-Care Tests, Genetic Testing, and Others), By Age Group, By Sector, By Geography |
||||||
カスタマイズ可能
|
|||||||
| 鎌状赤血球貧血の検査・スクリーニング市場：検査方法別、年齢層別、セクター別、地域別 |
|
出版日: 2024年11月26日
発行: Coherent Market Insights
ページ情報: 英文 130 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界の鎌状赤血球貧血検査・スクリーニング市場は、2024年には4億6,520万米ドルと推定され、2031年には10億2,810万米ドルに達すると予測され、2024年から2031年までのCAGRは12％を示すと予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年の市場規模 | 4億6,520万米ドル |
| 実績データ | 2019～2023年 | 予測期間 | 2024～2031年 |
| 予測期間2024～2031年 CAGR： | 12.00% | 2031年の価値予測 | 10億2,810万米ドル |
鎌状赤血球貧血は、赤血球がC字型または鎌状になる遺伝的な血液疾患です。鎌状赤血球貧血は、赤血球の形が崩れ、貧血を引き起こす疾患群です。この疾患は、サハラ以南のアフリカ、ラテンアメリカ、中米、インド出身の先祖を持つ人に多く見られます。世界の移民や渡航の増加に伴い、この疾患の有病率は多様な集団においても増加しています。早期スクリーニングプログラムは、この疾患の管理に役立ち、生涯にわたる治療とモニタリングを通じて合併症を予防することができます。
市場力学：
世界の鎌状赤血球貧血の検査・スクリーニング市場は、この遺伝性血液疾患の世界の有病率の増加によって牽引されています。2021年10月、世界保健機関（WHO）によると、毎年30万人以上の子供が鎌状赤血球貧血で生まれると推定されています。リスクのある人々の間で認識が高まり、出生前検査にスクリーニングが組み込まれることで、市場に有利な機会がもたらされています。しかし、新興国市場での採用率や認知度の低さが、市場の成長を抑制し続けています。精密医療と非侵襲的検査技術の開発は、予測期間中に課題を克服し、市場範囲をさらに拡大するのに役立ちます。
本調査の主な特徴
本レポートでは、世界の鎌状赤血球貧血の検査・スクリーニング市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模および複合年間成長率（CAGR%）を示します。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
鎌状赤血球貧血検査・スクリーニングの世界市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。
本調査の対象となる主要企業には、Bio-Rad Laboratories, Inc.、Thermo Fisher Scientific Inc.、Quest Diagnostics Incorporated、Agios Pharmaceuticals, Inc.、Bluebird bio, Inc.、PerkinElmer, Inc.、Laboratory Corporation of America Holdings、Global Blood Therapeutics, Inc.、Edvotek Inc.、Maternova Inc.、Hemex Health、CRISPR Therapeutics、Anamol Laboratories Pvt. Ltd.、Atlas Medical GmbH、Calibre Scientific, Inc.などがあります。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界の鎌状赤血球貧血検査・スクリーニング市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の鎌状赤血球貧血検査・スクリーニング市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
- 影響分析
- 主な発展
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- PORTERの分析
- 合併と買収のシナリオ
- 業界動向
第4章 鎌状赤血球貧血の検査・スクリーニングの世界市場、検査方法別、2019～2031年
- ヘモグロビン電気泳動
- 高速液体クロマトグラフィー（HPLC）
- ポイントオブケア検査
- 遺伝子検査
- その他
第5章 鎌状赤血球貧血の検査・スクリーニングの世界市場、年齢層別、2019～2031年
- 新生児スクリーニング
- 1～25歳
- 26歳以上
第6章 世界の鎌状赤血球貧血の検査・スクリーニング市場、セクター別、2019～2031年
- 政府の研究所
- 民間の研究所
- 企業の研究所
- 官民パートナーシップ（PPP）
第7章 世界の鎌状赤血球貧血検査・スクリーニング市場、地域別、2019～2031年
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第8章 競合情勢
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Agios Pharmaceuticals, Inc.
- Bluebird bio, Inc.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Global Blood Therapeutics, Inc.
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
第9章 アナリストの推奨事項
- 運命の輪
- アナリストの見解
- 一貫した機会マップ
第10章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
The global sickle cell anemia testing and screening market is estimated to be valued at USD 465.2 Mn in 2024 and is expected to reach USD 1,028.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 465.2 Mn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 12.00% | 2031 Value Projection: | US$ 1,028.1 Mn |
Sickle cell anemia is a genetic blood disorder that affects the red blood cells and causes them to take on a C-like or sickle shape. It is a group of disorders that causes the red blood cells to become misshapen and break down leasing to anemia. The disorder is more common in those with ancestry from sub-Saharan Africa, Latin America, Central America, and India. With increased immigration and travel globally, its prevalence has increased in diverse populations as well. Early screening programs can help in the management of the condition and prevent complications through lifelong treatment and monitoring.
Market Dynamics:
The global sickle cell anemia testing and screening market is driven by the increasing prevalence of the genetic blood disorder globally. In October 2021, as per the World Health Organization (WHO), it is estimated that over 300,000 children are born with sickle cell anemia each year. Growing awareness among at-risk populations and incorporating screening in prenatal testing are providing lucrative opportunities in the market. However, lower adoption and awareness levels in developing regions continues to restrain the market growth. Developments in precision medicine and non-invasive testing techniques can help overcome challenges and further expand the market reach during the forecast period.
Key Features of the Study:
This report provides in-depth analysis of the global sickle cell anemia testing and screening market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sickle cell anemia testing and screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agios Pharmaceuticals, Inc., Bluebird bio, Inc., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Global Blood Therapeutics, Inc., Edvotek Inc., Maternova Inc., Hemex Health, CRISPR Therapeutics, Anamol Laboratories Pvt. Ltd., Atlas Medical GmbH, and Calibre Scientific, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sickle cell anemia testing and screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sickle cell anemia testing and screening market
Market Segmentation
- By Testing Method Insights (Revenue, USD Mn, 2019 - 2031)
- Hemoglobin Electrophoresis
- High-Performance Liquid Chromatography (HPLC)
- Point-of-Care Tests
- Genetic Testing
- Others
- By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
- Newborn Screening
- Ages 1 to 25
- Ages 26 and Above
- By Sector Insights (Revenue, USD Mn, 2019 - 2031)
- Government Labs
- Private Labs
- Corporate Labs
- PPP (Public Private Partnerships)
- Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Agios Pharmaceuticals, Inc.
- Bluebird bio, Inc.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Global Blood Therapeutics, Inc.
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Sickle Cell Anemia Testing and Screening Market, By Testing Method
- Global Sickle Cell Anemia Testing and Screening Market, By Age Group
- Global Sickle Cell Anemia Testing and Screening Market, By Sector
- Global Sickle Cell Anemia Testing and Screening Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Sickle Cell Anemia Testing and Screening Market, By Testing Method, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hemoglobin Electrophoresis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- High-Performance Liquid Chromatography (HPLC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Point-of-Care Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Sickle Cell Anemia Testing and Screening Market, By Age Group, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Newborn Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Ages 1 to 25
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Ages 26 and Above
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Sickle Cell Anemia Testing and Screening Market, By Sector, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Government Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Private Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Corporate Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Public Private Partnerships (PPP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Sickle Cell Anemia Testing and Screening Market, By Region, 2019 - 2031, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country /Region, 2019 - 2031, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agios Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bluebird bio, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Global Blood Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
